Specific activation of latent HIV-1 by inhibiting E3 ubiquitin ligase activity

Medicine & Life Sciences

1. Ubiquitin-Protein Ligases 100%
2. HIV-1 76%
3. Proteasome Endopeptidase Complex 68%
4. Ubiquitin 66%
5. Virus Latency 60%
6. Lead 60%
7. Viruses 58%
8. High-Throughput Screening Assays 31%
9. Pharmaceutical Preparations 27%
10. Proteasome Inhibitors 26%
11. Highly Active Antiretroviral Therapy 24%
12. Ubiquitination 23%
13. Infections 20%
14. Drug Development 20%
15. Libraries 19%
16. Immunotherapy 19%
17. Molecular Weight 18%
18. Poisons 16%
19. T-Lymphocytes 13%
20. Gene Expression 13%
21. Genes 8%
22. Therapeutics 7%